The American Heart Association (AHA) accepted an $11 million donation from a drug company that produces a thrombolytic - a drug that breaks down blood clots - while preparing its guidelines on stroke management.
Drug companies hype the prevalence and seriousness of illnesses to market a new drug, a leading pharmaceutical executive has admitted.
Anyone who thought that the ‘gifts’ from pharmaceutical companies to doctors was a thing of the past needs to think again.